Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Actinium Pharmaceuticals (ATNM) Other Accumulated Expenses (2021 - 2022)

Actinium Pharmaceuticals (ATNM) has disclosed Other Accumulated Expenses for 2 consecutive years, with $934000.0 as the latest value for Q4 2022.

  • Quarterly Other Accumulated Expenses fell 6.41% to $934000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $934000.0 through Dec 2022, down 6.41% year-over-year, with the annual reading at $934000.0 for FY2022, 6.41% down from the prior year.
  • Other Accumulated Expenses for Q4 2022 was $934000.0 at Actinium Pharmaceuticals, up from $91000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $998000.0 in Q4 2021, with the low at $91000.0 in Q3 2022.